Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Special Programs for the Aging, Title III, Part B, Grants for Supportive Services and Senior Centers is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. To encourage State Agencies on Aging and Area Agencies on Aging to concentrate resources to develop and implement comprehensive and coordinated community-based systems of service for older individuals via Statewide planning, and area planning and provision of supportive services, including multipurpose senior centers. The objective of these services and centers is to maximize the informal support provided to older Americans to enable them to remain in their homes and communities. Providing transportation services, in-home services, and other support services, this program insures that elders receive the services they need to remain independent. This listing is currently active. Program number: 93.044. Last updated on 2026-01-21.
Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $410,000,000 (2026).; eligibility guidance Only State and U.S. Territories which have State Agencies on Aging designated by the Governors are eligible to receive these grants. Eligible applicant types include: U.S. State Government (including the District of Columbia), U.S. Territory (or Possession) Government (including freely-associated states).
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Based on current listing details, eligibility includes: Only State and U.S. Territories which have State Agencies on Aging designated by the Governors are eligible to receive these grants. Eligible applicant types include: U.S. State Government (including the District of Columbia), U.S. Territory (or Possession) Government (including freely-associated states). Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Recent federal obligations suggest $410,000,000 (2026). Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Diabetes, Digestive, Kidney Extramural Research - Research Centers is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. To promote extramural basic and clinical biomedical research that improves the understanding of the mechanisms underlying disease and leads to improved preventions, diagnosis, and treatment of diabetes, digestive, and kidney diseases. Programmatic areas within the National Institute of Diabetes and Digestive and Kidney Diseases include diabetes, digestive, endocrine, hematologic, liver, metabolic, nephrologic, nutrition, obesity, and urologic diseases. Specific programs areas of interest include the following: (a) For diabetes, endocrine, and metabolic diseases areas: Fundamental and clinical studies including the etiology, pathogenesis, prevention, diagnosis, treatment and cure of diabetes mellitus and its complications; Normal and abnormal function of the pituitary, thyroid, parathyroid, adrenal, and other hormone secreting glands; Hormonal regulation of bone, adipose tissue, and liver; on fundamental aspects of signal transduction, including the action of hormones, coregulators, and chromatin remodeling proteins; Hormone biosynthesis, secretion, metabolism, and binding; and on hormonal regulation of gene expression and the role(s) of selective receptor modulators as partial agonists or antagonists of hormone action; and Fundamental studies relevant to metabolic disorders including membrane structure, function, and transport phenomena and enzyme biosynthesis; and basic and clinical studies on the etiology, pathogenesis, prevention, and treatment of inherited metabolic disorders (such as cystic fibrosis). (b) For digestive disease and nutrition areas: Genetics and genomics of the GI tract and its diseases; Genetics and genomics of liver/pancreas and diseases; Genetics and genomics of nutrition; genetics and genomics of obesity; Bariatric surgery; Clinical nutrition research; Clinical obesity research; Complications of chronic liver disease; Fatty liver disease; Genetic liver disease; HIV and liver; Cell injury, repair, fibrosis and inflammation in the liver; Liver cancer; Liver transplantation; Pediatric liver disease; Viral hepatitis and infectious diseases; Gastrointestinal and nutrition effects of AIDS; Gastrointestinal mucosal and immunology; Gastrointestinal motility; Basic neurogastroenterology; Gastrointestinal development; Gastrointestinal epithelial biology; Gastrointestinal inflammation; Digestive diseases epidemiology and data systems; Nutritional epidemiology and data systems; Autoimmune liver disease; Bile, Bilirubin and cholestasis; Bioengineering and biotechnology related to digestive diseases, liver, nutrition and obesity; Cell and molecular biology of the liver; Developmental biology and regeneration; Drug-induced liver disease; Gallbladder disease and biliary diseases; Exocrine pancreas biology and diseases; Gastrointestinal neuroendocrinology; Gastrointestinal transport and absorption; Nutrient metabolism; Pediatric clinical obesity; Clinical trials in digestive diseases; Liver clinical trials; Obesity prevention and treatment; and Obesity and eating disorders. (c) For kidney, urologic and hematologic diseases areas: Studies of the development, physiology, and cell biology of the kidney; Pathophysiology of the kidney; Genetics of kidney disorders; Immune mechanisms of kidney disease; Kidney disease as a complication of diabetes; Effects of drugs, nephrotoxins and environmental toxins on the kidney; Mechanisms of kidney injury repair; Improved diagnosis, prevention and treatment of chronic kidney disease and end-stage renal disease; Improved approaches to maintenance dialysis therapies; Basic studies of lower urinary tract cell biology, development, physiology, and pathophysiology; Clinical studies of bladder dysfunction, incontinence, pyelonephritis, interstitial cystitis, benign prostatic hyperplasia, urolithiasis, and vesicoureteral reflux; Development of novel diagnostic tools and improved therapies, including tissue engineering strategies, for urologic disorders; Research on hematopoietic cell differentiation; metabolism of iron overload and deficiency; Structure, biosynthesis and genetic regulation of hemoglobin; as well as Research on the etiology, pathogenesis, and therapeutic modalities for the anemia of inflammation and chronic diseases. This listing is currently active. Program number: 93.KRC. Last updated on 2026-01-30. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $100,611,000 (2026).; eligibility guidance Eligible Organizations: Universities, colleges, medical, dental and nursing schools, schools of public health, laboratories, hospitals, State and local health departments, other public or private institutions, both non-profit and for-profit, and individuals who propose to establish, expand, and improve research activities in health sciences and related fields. Eligible Individuals (Program Director/Principal Investigator): Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Eligible applicant types include: Federally Recognized Indian/Native American/Alaska Native Tribal Government, Nonprofit Organization, U.S. State Government (including the District of Columbia), Small Business Person, Not-for-Profit Organization. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
National Library of Medicine - Small Business is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The National Library of Medicine (NLM) supports small business innovation in biomedical informatics—a multidisciplinary field that combines biomedical research with data science, informatics, and information technology. The program aims to encourage small businesses to develop novel technologies, tools, and platforms that can enhance health care delivery, biomedical research, data management, and health information dissemination. This listing is currently active. Program number: 93.LM5. Last updated on 2026-01-30. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $2,211,241 (2026).; eligibility guidance Eligible applicants are identified at the NOFO level. Eligible applicant types include: Small Business Person. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice.
Sexual Risk Avoidance Education is sponsored by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. The Sexual Risk Avoidance Education (SRAE) program funds prevention education projects that provide youth with information on how to avoid non-marital sexual activity and other risky behaviors. This listing is currently active. Program number: 93.060. Last updated on 2026-01-15. Application snapshot: target deadline rolling deadlines or periodic funding windows; published funding information Recent federal obligations suggest $35,000,000 (2026).; eligibility guidance Awards made under the authority of section 1110 of the Social Security Act, 42 U.S.C. § 1310 shall be made only to public and private entities that agree to use medically accurate information referenced to peer-reviewed publications by educational, scientific, governmental, or health organizations; implement an evidence-based approach integrating research findings with practical implementation that aligns with the needs and desired outcomes for the intended audience; and teach the benefits associated with self-regulation, success sequencing for poverty prevention, healthy relationships, goal setting, and resisting sexual coercion, dating violence, and other youth risk behaviors such as underage drinking or illicit drug use without normalizing teen sexual activity. Applications from individuals (including sole proprietorships) and foreign entities are not eligible and will be disqualified from the merit review and funding under this funding opportunity. Faith-based and community organizations that meet the eligibility requirements are eligible to receive awards under this funding opportunity. Eligible applicant types include: State, Small Business Person, Nonprofit Organization, For-Profit Organization, Tribal, U.S. Territory (or Possession) Government (including freely-associated states), Federally Recognized Indian/Native American/Alaska Native Tribal Government, Territorial. Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice. Applicants should map project outcomes and evaluation metrics directly to sponsor priorities and confirm all compliance requirements in the current official notice.
